Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Futura Medical (FUM)

Price 16.98p on 30-01-2025 at 17:30:00
Change -14.50p -46.77%
Buy 16.98p
Sell 16.02p
Buy / Sell FUM Shares
Last Trade: Unknown 909.00 at 16.50p
Day's Volume: 8,643,760
Last Close: 16.50p
Open: 20.00p
ISIN: GB0033278473
Day's Range 13.02p - 20.00p
52wk Range: 13.02p - 47.10p
Market Capitalisation: £52m
VWAP: 17.3998p
Shares in Issue: 304m

Recent Trades History Futura Medical (FUM)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 909 16.50p OTC Trade
16:19:40 - 30-Jan-25
Unknown* 354 16.72p OTC Trade
16:05:41 - 30-Jan-25
Buy* 1,146 16.66p Ordinary
16:29:35 - 30-Jan-25
Buy* 1,499 16.66p Ordinary
16:29:34 - 30-Jan-25
Buy* 38 16.98p SI Trade
16:28:24 - 30-Jan-25
Buy* 4,359 16.98p Automatic Execution
16:28:24 - 30-Jan-25
Buy* 2,929 16.66p Ordinary
16:28:16 - 30-Jan-25
Buy* 1,500 16.66p Ordinary
16:28:16 - 30-Jan-25
Buy* 59 16.931p Ordinary
16:28:09 - 30-Jan-25
Buy* 17,650 16.66p Ordinary
16:27:58 - 30-Jan-25

Share Price History for Futura Medical

Time period:
to
Date Open High Low Close Volume

Share News for Futura Medical

AIM WINNERS & LOSERS: Kromek wins deal; Futura Medical warns on profit

30th Jan 2025 11:03

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

IN BRIEF: Futura gets good results for female sexual dysfunction aid

16th Jan 2025 09:37

Futura Medical PLC - Guildford, Surrey-based sexual health products - Shares rise 4.5% on Wednesday as Futura reports positive results from a 'sensory' study of its WSD4000 treatment for sexual dysfunction in women. Futura explains that a sensory study assesses how healthy volunteers perceive product characteristics through their senses. The study involved 67 women with some degree of sexual dysfunction, and WSD4000 produced a positive change in a majority of them after four weeks. "Following the success of the study, alongside market research on the size of the opportunity following commercialisation, the board is recommending to proceed with an early feasibility study during H1 2025," Futura says. Read More

Futura Medical progresses study of female sexual dysfunction treatment

4th Nov 2024 10:57

(Alliance News) - Futura Medical PLC on Monday said it has progressed the development of its new product pipeline, including treatments for sexual dysfunction in both men and women. Read More

IN BRIEF: Futura Medical US pre-orders trigger milestone payment

7th Oct 2024 11:06

Futura Medical PLC - Surrey-based sexual health products company - Announces that the next milestone payment of USD5.0 million, due under its agreement with Haleon PLC, has been triggered by Haleon's distribution of online pre-orders and the availability of Eroxon in US retailers. Eroxon is a fast-acting gel used to treat erectile dysfunction, which has been available without a prescription in UK pharmacies since March last year. Futura Medical struck a licensing deal with Haleon for the gel in July 2023, which has led to its availability in the US from October this year. Futura Medical expects to receive the payment from Haleon shortly. Read More

EARNINGS AND TRADING: Blackbird loss narrows; Futura Medical in profit

10th Sep 2024 21:21

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

FTSE 100 Latest
Value8,646.88
Change89.07

Login to your account

Forgot Password?

Not Registered